Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP316009.RAdlDc3GhmgUbBjD-34DefJWRnRL79-b7UIoOD-mrLp3c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP316009.RAdlDc3GhmgUbBjD-34DefJWRnRL79-b7UIoOD-mrLp3c130_assertion type Assertion NP316009.RAdlDc3GhmgUbBjD-34DefJWRnRL79-b7UIoOD-mrLp3c130_head.
- NP316009.RAdlDc3GhmgUbBjD-34DefJWRnRL79-b7UIoOD-mrLp3c130_assertion description "[Our study provides proof-of-principle that tpp1(sa0011)(-/-) mutants can utilize the advantages of zebrafish for understanding pathogenesis and drug discovery in CLN2 disease and other epilepsies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP316009.RAdlDc3GhmgUbBjD-34DefJWRnRL79-b7UIoOD-mrLp3c130_provenance.
- NP316009.RAdlDc3GhmgUbBjD-34DefJWRnRL79-b7UIoOD-mrLp3c130_assertion evidence source_evidence_literature NP316009.RAdlDc3GhmgUbBjD-34DefJWRnRL79-b7UIoOD-mrLp3c130_provenance.
- NP316009.RAdlDc3GhmgUbBjD-34DefJWRnRL79-b7UIoOD-mrLp3c130_assertion SIO_000772 23587805 NP316009.RAdlDc3GhmgUbBjD-34DefJWRnRL79-b7UIoOD-mrLp3c130_provenance.
- NP316009.RAdlDc3GhmgUbBjD-34DefJWRnRL79-b7UIoOD-mrLp3c130_assertion wasDerivedFrom befree-20150227 NP316009.RAdlDc3GhmgUbBjD-34DefJWRnRL79-b7UIoOD-mrLp3c130_provenance.
- NP316009.RAdlDc3GhmgUbBjD-34DefJWRnRL79-b7UIoOD-mrLp3c130_assertion wasGeneratedBy ECO_0000203 NP316009.RAdlDc3GhmgUbBjD-34DefJWRnRL79-b7UIoOD-mrLp3c130_provenance.